Monday, September 27, 2021
Home DCGI Approves Phase 2, 3 Clinical Trials of COVAXIN on Children Aged 2 to 18 Years DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to 18 years

DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to 18 years

DCGI Approves Phase 2, 3 Clinical Trials of COVAXIN on Children Aged 2 to 18 Years
- Advertisement -

MOST POPULAR

HOT NEWS

The Indian Weekly